Opioids in cancer: The κ‑opioid receptor (Review)

Mol Med Rep. 2022 Feb;25(2):44. doi: 10.3892/mmr.2021.12560. Epub 2021 Dec 8.

Abstract

The κ‑opioid receptor (KOR) is one of the primary receptors of opioids and serves a vital role in the regulation of pain, anesthesia, addiction and other pathological and physiological processes. KOR is associated with several types of cancer and may influence cancer progression. It has been proposed that KOR may represent a new tumor molecular marker and provide a novel basis for molecular targeted therapies for cancer. However, the association between KOR and cancer remains to be explored comprehensively. The present review introduces KOR and its association with different types of cancer. Improved understanding of KOR may facilitate development of novel antitumor therapies.

Keywords: cancer; opioid; tumor; κ‑opioid receptor.

Publication types

  • Review

MeSH terms

  • Analgesics, Opioid / metabolism*
  • Animals
  • Disease Progression
  • Humans
  • Hypoxia / metabolism*
  • Inflammation / metabolism*
  • Neoplasms / metabolism*
  • Neovascularization, Pathologic*
  • Receptors, Opioid, kappa / chemistry
  • Receptors, Opioid, kappa / physiology*

Substances

  • Analgesics, Opioid
  • Receptors, Opioid, kappa

Grants and funding

The present study was supported by the Clinical Medical Technology Innovation Project of Hunan (grant nos. 2020SK51903 and 2018SK51702).